SOURCE 3: 1-year outcomes post-transcatheter aortic valve implantation using the latest generation of the balloon-expandable transcatheter heart valve

European Heart Journal

Volumn 38, Issue 36, 2017, Pages 2717-2726

  Wendler, Olaf ^a   Schymik, Gerhard ^b   Treede, Hendrik ^c   Baumgartner, Helmut ^d   Dumonteil, Nicolas ^e   Neumann, Franz Josef ^f   Tarantini, Giuseppe ^g   Zamorano, Jose Luis ^h   Vahanian, Alec ⁱ  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b Municipal Hospital Karlsruhe   (Germany)

^c MARTIN LUTHER UNIVERSITÄT HALLE WITTENBERG   (Germany)

^d UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^e CLINIQUE PASTEUR   (France)

^f UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^g UNIVERSITY OF PADOVA   (Italy)

^h HOSPITAL RAMÓN Y CAJAL   (Spain)

ⁱ BICHAT HOSPITAL   (France)

Author keywords

Aortic stenosis; Balloon expandable valve; Causes of death; Predictors of mortality; SAPIEN 3; Transcatheter aortic valve implantation

Indexed keywords

AGED; ALL CAUSE MORTALITY; AORTIC STENOSIS; ARTICLE; BALLOON DILATATION; BALLOON EXPANDABLE TRANSCATHETER HEART VALVE PROSTHESIS; BODY MASS; CARDIOVASCULAR MORTALITY; CAUSE OF DEATH; CLINICAL OUTCOME; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CONVERSION TO OPEN SURGERY; ENDOCARDITIS; FEMALE; FOLLOW UP; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEMODYNAMICS; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NEW YORK HEART ASSOCIATION CLASS; NEW-ONSET ATRIAL FIBRILLATION; OBSERVATIONAL STUDY; OPEN HEART SURGERY; OUTCOME ASSESSMENT; PARAVALVULAR LEAK; PERCUTANEOUS AORTIC VALVE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROSTHETIC VALVE THROMBOSIS; SUDDEN CARDIAC DEATH; TRANSCATHETER AORTIC VALVE IMPLANTATION; TRICUSPID VALVE REGURGITATION; VERY ELDERLY; AORTIC VALVE STENOSIS; CLINICAL TRIAL; CONVALESCENCE; DEVICES; HEART VALVE PROSTHESIS; MULTICENTER STUDY; PHYSIOLOGY; POSTOPERATIVE COMPLICATION; PROCEDURES; TRANSLUMINAL CORONARY ANGIOPLASTY; TREATMENT OUTCOME;

AGED, 80 AND OVER; ANGIOPLASTY, BALLOON, CORONARY; AORTIC VALVE STENOSIS; CAUSE OF DEATH; FEMALE; HEART VALVE PROSTHESIS; HEMODYNAMICS; HUMANS; MALE; POSTOPERATIVE COMPLICATIONS; RECOVERY OF FUNCTION; TRANSCATHETER AORTIC VALVE REPLACEMENT; TREATMENT OUTCOME;

EID: 85030099229     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehx294     Document Type: Article

References (12)

1. Leon MB, Smith CR, Mack MJ, Makkar RR, Svensson LG, Kodali SK, Thourani VH, Tuzcu EM, Miller DC, Herrmann HC, Doshi D, Cohen DJ, Pichard AD, Kapadia S, Dewey T, Babaliaros V, Szeto WY, Williams MR, Kereiakes D, Zajarias A, Greason KL, Whisenant BK, Hodson RW, Moses JW, Trento A, Brown DL, Fearon WF, Pibarot P, Hahn RT, Jaber WA, Anderson WN, Alu MC, Webb JG, Investigators P. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med 2016;374:1609-1620.
2. Thomas M, Schymik G, Walther T, Himbert D, Lefèvre T, Treede H, Eggebrecht H, Rubino P, Colombo A, Lange R, Schwarz RR, Wendler O. One-year outcomes of cohort 1 in the Edwards SAPIEN aortic bioprosthesis european outcome (SOURCE) registry: the European registry of transcatheter aortic valve implantation using the Edwards SAPIEN valve. Circulation 2011;124:425-433.
3. Schymik G, Lefèvre T, Bartorelli AL, Rubino P, Treede H, Walther T, Baumgartner H, Windecker S, Wendler O, Urban P, Mandinov L, Thomas M, Vahanian A. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry. JACC Cardiovasc Interv 2015;8:657-669.
4. Webb J, Gerosa G, Lefèvre T, Leipsic J, Spence M, Thomas M, Thielmann M, Treede H, Wendler O, Walther T. Multicenter evaluation of a next-generation balloon-expandable transcatheter aortic valve. J Am Coll Cardiol 2014;64:2235-2243.
5. Wendler O, Schymik G, Treede H, Baumgartner H, Dumonteil N, Ihlberg L, Neumann FJ, Tarantini G, Zamorano JL, Vahanian A. SOURCE 3 Registry: design and 30-day results of the European post approval registry of the latest generation of the Sapien 3TM transcatheter heart valve. Circulation 2017;135:1123-1132.
6. Vahanian A, Alfieri O, Andreotti F, Antunes MJ, Baron-Esquivias G, Baumgartner H, Borger MA, Carrel TP, De Bonis M, Evangelista A, Falk V, Lung B, Lancellotti P, Pierard L, Price S, Schafers HJ, Schuler G, Stepinska J, Swedberg K, Takkenberg J, Von Oppell UO, Windecker S, Zamorano JL, Zembala M; ESC Committee for Practice Guidelines (CPG); Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC); European Association for Cardio-Thoracic Surgery (EACTS). Guidelines on the management of valvular heart disease (version 2012): the Joint Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 2012;33:2569-2619.
7. Muñoz-Garc?a AJ, Muñoz-Garc?a E, Jiménez-Navarro MF, Dom?nguez-Franco AJ, Alonso-Briales JH, Hernandez-Garc?a JM, de Teresa-Galvan E; RIC Investigators. Clinical impact of acute kidney injury on short-and long-term outcomes after transcatheter aortic valve implantation with the CoreValve prosthesis. J Cardiol 2015;66:46-49.
8. Schnabel RB, Seiffert M, Wilde S, Schirmer J, Koschyk DH, Conradi L, Ojeda F, Baldus S, Reichenspurner H, Blankenberg S, Treede H, Diemert P. Kidney injury and mortality after transcatheter aortic valve implantation in a routine clinical cohort. Catheter Cardiovasc Interv 2015;85:440-447.
9. Herrmann HC, Thourani VH, Kodali SK, Makkar RR, Szeto WY, Anwaruddin S, Desai N, Lim S, Malaisrie SC, Kereiakes DJ, Ramee S, Greason KL, Kapadia S, Babaliaros V, Hahn RT, Pibarot P, Weissman NJ, Leipsic J, Whisenant BK, Webb JG, Mack MJ, Leon MB; PARTNER Investigators. One-year clinical outcomes with SAPIEN 3 transcatheter aortic valve replacement in high-risk and inoperable patients with severe aortic stenosis. Circulation 2016;134: 130-140.
10. Meredith IT, Walters DL, Dumonteil N, Worthley SG, Tchétché D, Manoharan G, Blackman DJ, Rioufol G, Hildick-Smith D, Whitbourn RJ, Lefèvre T, Lange R, Müller R, Redwood S, Feldman TE, Allocco DJ, Dawkins KD. 1-year outcomes with the fully repositionable and retrievable Lotus transcatheter aortic replacement valve in 120 high-risk surgical patients with severe aortic stenosis: results of the REPRISE II Study. JACC Cardiovasc Interv 2016;9:376-384.
11. Lefèvre T, Colombo A, Tchétché D, Latib A, Klugmann S, Fajadet J, De Marco F, Maisano F, Bruschi G, Bijuklic K, Nava S, Weissman N, Low R, Thomas M, Young C, Redwood S, Mullen M, Yap J, Grube E, Nickenig G, Sinning JM, Hauptmann KE, Friedrich I, Lauterbach M, Schmoeckel M, Davidson C, Schofer J. Prospective multicenter evaluation of the Direct Flow medical transcatheter aortic valve system: 12-month outcomes of the evaluation of the Direct Flow Medical percutaneous aortic valve 18F system for the treatment of patients with severe aortic stenosis (DISCOVER) Study. JACC Cardiovasc Interv 2016;9:68-75.
12. Linke A, Wenaweser P, Gerckens U, Tamburino C, Bosmans J, Bleiziffer S, Blackman D, Schafer U, Müller R, Sievert H, Søndergaard L, Klugmann S, Hoffmann R, Tchétché D, Colombo A, Legrand VM, Bedogni F, lePrince P, Schuler G, Mazzitelli D, Eftychiou C, Frerker C, Boekstegers P, Windecker S, Mohr FW, Woitek F, Lange R, Bauernschmitt R, Brecker S. ADVANCE study Investigators. Treatment of aortic stenosis with a self-expanding transcatheter valve: the international multi-centre ADVANCE Study. Eur Heart J 2014;35:2672-2684.